Interventional Oncology Ablation Market, by Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, and Irreversible Electroporation Ablation), by Indication (Liver Cancer, Kidney Cancer, Lung Cancer, and Others), by End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Interventional oncology ablation is a minimally invasive procedure to treat solid cancers. In this procedure, special probes are used to burn or freeze cancer tumors without the usual surgery.
Market Dynamics
The increasing incidence of cancer is expected to drive the growth of global interventional oncology ablation market over the forecast period.
For instance, according to the World Health Organization statistics published in March 2021, cancer is the second leading cause of death globally and is responsible for about 10 million deaths per year, and globally about one in six deaths are due to cancer. Furthermore, according to the same source, an estimated 9.6 million deaths occurred due to cancer in 2018 globally.
Key features of the study:
This report provides in-depth analysis of the global interventional oncology ablation market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global interventional oncology ablation market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Boston Scientific Corporation, Johnson & Johnson, Medtronic Plc, Varian Medical Systems, Inc., EDAP TMS S.A., AngioDynamics, CASCINATION AG, Merit Medical Systems, Inc., STARmed Co., and Biomedical Srl.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global interventional oncology ablation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global interventional oncology ablation market
Detailed Segmentation:
Global Interventional Oncology Ablation Market, By Technology:
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Irreversible Electroporation Ablation
Global Interventional Oncology Ablation Market, By Indication:
Liver Cancer
Kidney cancer
Lung Cancer
Others
Global Interventional Oncology Ablation Market, By End User:
Hospitals & Clinics
Ambulatory Surgical Centers
Others
Global Interventional Oncology Ablation Market, By Region:
North America
By Technology
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Irreversible Electroporation Ablation
By Indication
Liver Cancer
Kidney cancer
Lung Cancer
Others
By End User
Hospitals & Clinics
Ambulatory Surgical Centers
Others
By Country
U.S.
Canada
Latin America
By Technology
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Irreversible Electroporation Ablation
By Indication
Liver Cancer
Kidney cancer
Lung Cancer
Others
By End User
Hospitals & Clinics
Ambulatory Surgical Centers
Others
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Technology
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Irreversible Electroporation Ablation
By Indication
Liver Cancer
Kidney cancer
Lung Cancer
Others
By End User
Hospitals & Clinics
Ambulatory Surgical Centers
Others
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Technology
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Irreversible Electroporation Ablation
By Indication
Liver Cancer
Kidney cancer
Lung Cancer
Others
By End User
Hospitals & Clinics
Ambulatory Surgical Centers
Others
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Technology
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Irreversible Electroporation Ablation
By Indication
Liver Cancer
Kidney cancer
Lung Cancer
Others
By End User
Hospitals & Clinics
Ambulatory Surgical Centers
Others
By Country
GCC
Israel
Rest of Middle East
Africa
By Technology
Radiofrequency Ablation
Microwave Ablation
Cryoablation
Irreversible Electroporation Ablation
By Indication
Liver Cancer
Kidney cancer
Lung Cancer
Others
By End User
Hospitals & Clinics
Ambulatory Surgical Centers
Others
By Country/Region
South Africa
Central Africa
North Africa
Company Profiles
Boston Scientific Corporation*
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Johnson & Johnson
Medtronic Plc
Varian Medical Systems, Inc.
EDAP TMS S.A.
AngioDynamics
CASCINATION AG
Merit Medical Systems, Inc.
STARmed Co.
Biomedical Srl
“*” marked represents similar segmentation in other categories in the respective section.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook